Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g Bid on Nutritional Status in Subjects With IBS-D

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

November 1, 2016

Study Completion Date

November 2, 2016

Conditions
Diarrhea-predominant Irritable Bowel Syndrome
Interventions
OTHER

Serum-derived bovine immunoglobulin protein isolate (SBI)

Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g bid on Nutritional Status and intestinal functions in Subjects with IBS-D

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT02163213 - Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g Bid on Nutritional Status in Subjects With IBS-D | Biotech Hunter | Biotech Hunter